AAAAAA

   
Results: 1-19 |
Results: 19
PROPHYLACTIC USE OF ANTIBIOTICS DURING TREATMENT WITH CPT-11 (CAMPTO(R)) FOR METASTATIC COLORECTAL-CANCER [MCC] - A RANDOMIZED MULTICENTER TRIAL
Authors: STUPP R FOCAN C SESSA C NOWACKI M VANDENBOSSCHE G CANON JL ZALUSKI J OULIDAISSA D BOUSSARD B PESTALOZZI B
Citation: R. Stupp et al., PROPHYLACTIC USE OF ANTIBIOTICS DURING TREATMENT WITH CPT-11 (CAMPTO(R)) FOR METASTATIC COLORECTAL-CANCER [MCC] - A RANDOMIZED MULTICENTER TRIAL, Annals of oncology, 9, 1998, pp. 163-163
TREATMENT WITH CPT-11 (CAMPTO(R)) IN THE COMMUNITY - RESULTS OF THE SWISS COMPASSIONATE USE PROGRAM
Authors: STUPP R ROTH A BORNER M HOFMANN V KUNG C MORANT R
Citation: R. Stupp et al., TREATMENT WITH CPT-11 (CAMPTO(R)) IN THE COMMUNITY - RESULTS OF THE SWISS COMPASSIONATE USE PROGRAM, Annals of oncology, 9, 1998, pp. 209-209
TAXOTERE-CISPLATIN-5FU (TCF) IN ADVANCED GASTRIC-CARCINOMA (AGC) - A PHASE I-II STUDY
Authors: ROTH AD MAIBACH R MORANT R PAGANI O DEBRAUD F BORNER MM STUPP R HERRMANN R FAZIO N SESSA C GOLDHIRSCH A
Citation: Ad. Roth et al., TAXOTERE-CISPLATIN-5FU (TCF) IN ADVANCED GASTRIC-CARCINOMA (AGC) - A PHASE I-II STUDY, Annals of oncology, 9, 1998, pp. 232-232
CARBOPLATIN AND PACLITAXEL (TAXOL(R)) FOR NONSMALL CELL LUNG-CANCER [NSCLC], A STANDARD REGIMEN
Authors: PRALONGKOHLER J STUPP R MONNERAT C BAUER J STALDER M PEREY L LEYVRAZ S
Citation: J. Pralongkohler et al., CARBOPLATIN AND PACLITAXEL (TAXOL(R)) FOR NONSMALL CELL LUNG-CANCER [NSCLC], A STANDARD REGIMEN, Annals of oncology, 9, 1998, pp. 420-420
RECOMBINANT INTERFERON-BETA (REBIF(R)) AS A RADIOSENSITIZER IN NON-SMALL-CELL LUNG-CANCER (NSCLC) - EARLY RESULTS OF A PHASE I II TRIAL/
Authors: STUPP R ROWELL NP ORECCHIA R OZSAHIN M POPOWSKI Y AAPRO MS MICHEL G KRENGLI M WEINER J GOEDKOOP R MIRIMANOFF RO
Citation: R. Stupp et al., RECOMBINANT INTERFERON-BETA (REBIF(R)) AS A RADIOSENSITIZER IN NON-SMALL-CELL LUNG-CANCER (NSCLC) - EARLY RESULTS OF A PHASE I II TRIAL/, Annals of oncology, 9, 1998, pp. 328-328
PHASE-I STUDY OF CONCOMITANT CHEMORADIOTHERAPY WITH PACLITAXEL, FLUOROURACIL, AND HYDROXYUREA WITH GRANULOCYTE-COLONY-STIMULATING FACTOR SUPPORT FOR PATIENTS WITH POOR-PROGNOSIS CANCER OF THE HEAD AND NECK
Authors: BROCKSTEIN B HARAF DJ STENSON K FASANMADE A STUPP R GLISSON B LIPPMAN SM RATAIN MJ SULZEN L KLEPSCH A WEICHSELBAUM RR VOKES EE
Citation: B. Brockstein et al., PHASE-I STUDY OF CONCOMITANT CHEMORADIOTHERAPY WITH PACLITAXEL, FLUOROURACIL, AND HYDROXYUREA WITH GRANULOCYTE-COLONY-STIMULATING FACTOR SUPPORT FOR PATIENTS WITH POOR-PROGNOSIS CANCER OF THE HEAD AND NECK, Journal of clinical oncology, 16(2), 1998, pp. 735-744
INTERIM RESULTS OF A PHASE-II STUDY OF DOCETAXEL (TAXOTERE(R)) IN UNRESECTABLE NONSMALL CELL LUNG-CANCER (NSCLC) ON 204 CHEMOTHERAPY NAIVE OR PRETREATED PATIENTS
Authors: MATTSON K LECHEVALIER T BOSQUEE L PUJOL JL CULINE S DABOUIS G LEGROUMELLEC A STUPP R BOYER R BERILLE J
Citation: K. Mattson et al., INTERIM RESULTS OF A PHASE-II STUDY OF DOCETAXEL (TAXOTERE(R)) IN UNRESECTABLE NONSMALL CELL LUNG-CANCER (NSCLC) ON 204 CHEMOTHERAPY NAIVE OR PRETREATED PATIENTS, European journal of cancer, 33, 1997, pp. 1036-1036
THE 6TH-LUGANO-CONFERENCE - BASIC SCIENCE PAPERS - INTRODUCTION
Authors: ONG ST STUPP R ULTMANN JE
Citation: St. Ong et al., THE 6TH-LUGANO-CONFERENCE - BASIC SCIENCE PAPERS - INTRODUCTION, Annals of oncology, 8, 1997, pp. 1-2
ONE AND A HALF DECADES OF THE LUGANO INTERNATIONAL-CONFERENCE ON MALIGNANT-LYMPHOMA - VARIATIONS ON A THEME OR TRUE PROGRESS
Authors: ULTMANN JE ONG ST STUPP R
Citation: Je. Ultmann et al., ONE AND A HALF DECADES OF THE LUGANO INTERNATIONAL-CONFERENCE ON MALIGNANT-LYMPHOMA - VARIATIONS ON A THEME OR TRUE PROGRESS, Annals of oncology, 8, 1997, pp. 1-3
THE 6TH LUGANO-CONFERENCE CLINICAL PAPERS - MANY REMAINING QUESTIONS
Authors: STUPP R ONG ST ULTMANN JE
Citation: R. Stupp et al., THE 6TH LUGANO-CONFERENCE CLINICAL PAPERS - MANY REMAINING QUESTIONS, Annals of oncology, 8, 1997, pp. 5-6
THE ROLE OF PACLITAXEL IN THE TREATMENT OF HEAD AND NECK-CANCER
Authors: VOKES EE HARAF DJ STENSON K STUPP R MALONE D LEVIN J WEICHSELBAUM RR
Citation: Ee. Vokes et al., THE ROLE OF PACLITAXEL IN THE TREATMENT OF HEAD AND NECK-CANCER, Seminars in oncology, 22(5), 1995, pp. 8-12
HYDROXYUREA WITH CONTINUOUS-INFUSION PACLITAXEL, 5-FLUOROURACIL, AND CONCOMITANT RADIOTHERAPY FOR POOR-PROGNOSIS HEAD AND NECK-CANCER
Authors: VOKES EE STUPP R HARAF D MORAN W MALONE D WENIG B SWEENEY P WEICHSELBAUM RR
Citation: Ee. Vokes et al., HYDROXYUREA WITH CONTINUOUS-INFUSION PACLITAXEL, 5-FLUOROURACIL, AND CONCOMITANT RADIOTHERAPY FOR POOR-PROGNOSIS HEAD AND NECK-CANCER, Seminars in oncology, 22(3), 1995, pp. 47-52
MANAGEMENT OF LYMPHOMA IN THE 1990S - INTRODUCTION TO THE PROCEEDINGSOF THE 5TH INTERNATIONAL-CONFERENCE ON MALIGNANT-LYMPHOMA
Authors: STUPP R SAMUELS BL ULTMANN JE
Citation: R. Stupp et al., MANAGEMENT OF LYMPHOMA IN THE 1990S - INTRODUCTION TO THE PROCEEDINGSOF THE 5TH INTERNATIONAL-CONFERENCE ON MALIGNANT-LYMPHOMA, Annals of oncology, 5, 1994, pp. 190000001-190000003
THE LUGANO INTERNATIONAL CONFERENCES ON MALIGNANT-LYMPHOMA, 1981-1993- OVERVIEW
Authors: SAMUELS BL STUPP R ULTMANN JE
Citation: Bl. Samuels et al., THE LUGANO INTERNATIONAL CONFERENCES ON MALIGNANT-LYMPHOMA, 1981-1993- OVERVIEW, Annals of oncology, 5, 1994, pp. 190000001-190000004
5TH INTERNATIONAL-CONFERENCE ON MALIGNANT-LYMPHOMA .1. INTRODUCTION
Authors: SAMUELS BL STUPP R ULTMANN JE
Citation: Bl. Samuels et al., 5TH INTERNATIONAL-CONFERENCE ON MALIGNANT-LYMPHOMA .1. INTRODUCTION, Annals of oncology, 5, 1994, pp. 190000005-190000006
COMBINED-MODALITY THERAPY OF HEAD AND NECK-CANCER
Authors: STUPP R WEICHSELBAUM RR VOKES EE
Citation: R. Stupp et al., COMBINED-MODALITY THERAPY OF HEAD AND NECK-CANCER, Seminars in oncology, 21(3), 1994, pp. 349-358
LOW-DOSE ORAL CYCLOPHOSPHAMIDE (CTX) FOR THE TREATMENT OF HORMONE-REFRACTORY PROSTATE-CANCER (HRPC)
Authors: ONG ST STUPP R VOGELZANG NJ
Citation: St. Ong et al., LOW-DOSE ORAL CYCLOPHOSPHAMIDE (CTX) FOR THE TREATMENT OF HORMONE-REFRACTORY PROSTATE-CANCER (HRPC), Clinical research, 42(3), 1994, pp. 10000376-10000376
THE VALUE OF SUPPORTIVE CARE AND PREVENTION OF SIDE-EFFECTS TO THE PATIENT
Authors: STUPP R STOCKING C RATAIN M RICHARDSON J LIST M SIEGLER M
Citation: R. Stupp et al., THE VALUE OF SUPPORTIVE CARE AND PREVENTION OF SIDE-EFFECTS TO THE PATIENT, Clinical research, 41(3), 1993, pp. 10000645-10000645
LONG-TERM EXPERIENCE WITH CISPLATIN-BASED INDUCTION CHEMOTHERAPY AND CONCOMITANT CHEMORADIOTHERAPY IN LOCALLY ADVANCED HEAD AND NECK-CANCER(HNC)
Authors: STUPP R HARAF D KOZLOFF M MCEVILLY J WEICHSELBAUM R VOKES E
Citation: R. Stupp et al., LONG-TERM EXPERIENCE WITH CISPLATIN-BASED INDUCTION CHEMOTHERAPY AND CONCOMITANT CHEMORADIOTHERAPY IN LOCALLY ADVANCED HEAD AND NECK-CANCER(HNC), Clinical research, 41(3), 1993, pp. 10000647-10000647
Risultati: 1-19 |